pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Wegovy · news · pharmadog
← back to Wegovy
News mentioning Wegovy
133
stories
Jul 6, 26
STAT+: Online GLP-1 prescriptions are often fast, easy — and low on clinical oversight
stat
Jul 6, 26
Opinion: The smart way to regulate the peptide boom
stat
Jul 2, 26
STAT+: Pharmalittle: We’re reading about a court win for Amgen, Novo seeking supplier discounts, and more
stat
Jun 18, 26
What’s next for GLP-1 weight loss drugs?
stat
Jun 17, 26
UK waitlist for Novo's Wegovy pill triples in week after approval, major online pharmacy says
endpoints
Jun 16, 26
STAT+: Pharmalittle: We’re reading about Medicare and obesity drugs, Germany’s pricing plans, and more
stat
Jun 10, 26
Are Republicans turning against medications for treating opioid addiction?
stat
Jun 8, 26
ADA ‘26: Lilly’s dominance, Pfizer’s ‘foundational’ drug and Roche’s ‘me-too’ option
biopharma dive
Jun 7, 26
STAT+: New data may cast doubt on competitiveness of Boehringer’s obesity drug
stat
Jun 3, 26
STAT+: Pharmalittle: We’re reading about GLP-1 drugs and knees, FDA cell and gene therapy guidance, and more
stat
Jun 1, 26
STAT+: Medicare’s mum on GLP-1s, and Massachusetts sues United
stat
Jun 1, 26
STAT+: Pharmalittle: We’re reading about pancreatic and lung cancer drugs, China biotech growth, and more
stat
Jun 1, 26
CDC says containing the spread of Ebola is top priority
stat
Jun 1, 26
STAT+: Medicare still won’t say how much covering obesity drugs will cost
stat
May 29, 26
Which vaccines will curb the Ebola outbreak? WHO debates
stat
May 29, 26
Opinion: I’m a weight-loss doctor. Here’s why I worry about GLP-1 ‘microdoses’
stat
May 28, 26
CVS obesity drug deal puts Lilly on equal footing with Novo
biopharma dive
May 13, 26
Lilly data point to ‘maintenance’ strategies for GLP-1 weight loss
biopharma dive
May 13, 26
STAT+: Pharmalittle: We’re reading about FDA’s Makary resigning, a Lilly weight loss drug trial, and more
stat
May 12, 26
STAT+: Pharmalittle: We’re reading about pharma lobbying, Bristol’s deal with a Chinese partner, and more
stat
May 11, 26
Rezdiffra is exceeding Wall Street's expectations as the MASH market takes shape
endpoints
May 7, 26
Amazon adds Ozempic pill to same-day prescription drug kiosks
endpoints
May 7, 26
Entrada stock falls on Duchenne data; Wegovy expands access
endpoints
May 7, 26
STAT+: FDA revisits a rare cancer treatment it rejected a few months ago
stat
May 7, 26
STAT+: FDA to reconsider treatment for rare cancer after its surprise rejection
stat
May 7, 26
STAT+: Next-gen Duchenne drug from Entrada disappoints
stat
May 7, 26
STAT+: Angelini Pharma buys Catalyst Pharmaceuticals and its rare disease drugs for $4.1B
stat
May 6, 26
STAT+: Oregon hospitals won’t outsource to national physician chain after all
stat
May 6, 26
STAT+: Color Health moving deeper into cancer services, complete with virtual ‘tumor boards’
stat
May 6, 26
Novo hikes guidance on Wegovy pill’s fast sales start
biopharma dive
← prev
page 4 of 5
next →
